North Jersey Community Research Initiative (NJCRI) Study on Transgender Liver Health
Part of paid clinical trials in Newark, New Jersey.
- Sponsor
- Corey DeStefano
- Study ID
- NCT07746999
- Status
- Enrolling By Invitation
Conditions
- HEPATITIS C (HCV)
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Accepted
Study Details
Primary Objective: Assess disparities in liver health outcomes among transgender individuals on GAHT by evaluating liver function markers (transaminases, bilirubin levels, etc), as well as liver elasticity and presence of liver steatosis or Nonalcoholic Fatty Liver Disease (NAFLD) through FibroScan. A total of 60 participants will be recruited throughout the study, with a ratio of 1:1 between transgender participants who have been on GAHT more than 6 months ( = or \> 182 days), and transgender participants who have been on GAHT for less than 6 months ( \< 181 days) at the start of the study. Secondary Objectives: Assess liver health-related risk factors (e.g. obesity, alcohol consumption) in transgender population. Investigate the association between specific hormone regimens and liver function in transgender individuals. Explore potential modifiers of liver health outcomes, such as age, social barriers determinants of health, duration of hormone therapy and adherence to medical guidelines. Change in Quality of Life from baseline to last study visit.
Key Dates
- First listed
- Aug 5, 2026
- Start date
- Mar 15, 2025
- Status verified
- Jul 2026
- Primary completion
- Mar 15, 2027
- Completion
- Mar 15, 2027
Study Design
- Enrollment
- 60 participants (estimated)
Arms
- Arm: Transgender >6 months on GAHT and Transgender <6 months on GAHTA total of 60 participants will be recruited throughout the study, with a ratio of 1:1 between transgender participants who have been on GAHT more than 6 months ( = or \> 182 days), and transgender participants who have been on GAHT for less than 6 months ( \< 181 days) at the start of the study
Primary Outcome Measure
Assess disparities in liver health outcomes among transgender individuals [ Time Frame: Baseline through December 2027 ]
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| North Jersey AIDS Alliance dba North Jersey Community Research Initiative (NJCRI) | Newark | New Jersey | 07103 | - |
Find similar trials in Newark, NJ
Related Studies
- Persuasive Health Communication Intervention for HIV/HCVRecruiting · University of South Florida · New York, New York
- Trauma-informed, Resilience-based Telehealth Intervention for Improving HIV Prevention and HCV Care for Persons Who Inject Drugs in the Deep South (Pilot Testing: Aim3)Not Yet Recruiting · University of Georgia · Colbert, Georgia
- Implementing Low-Barrier HCV Treatment in a Jail SettingPHASE4 · Recruiting · Lifespan · Cranston, Rhode Island
- Rapid HIV, Hep C, and Syphilis Screening in a Rural Street Medicine ClinicNot Yet Recruiting · West Virginia University · Harpers Ferry, West Virginia